Actress Tracy Shaw, 52, posted an Instagram video on Thursday confirming she completed her first day of chemotherapy for HER2‑positive breast cancer. She described a full‑day hospital stay from 9 am to 5:30 pm, noted a metallic taste in her mouth and thanked NHS staff for their support.

Tracy Shaw’s 9 am‑5:30 pm chemotherapy marathon

According to the Instagram update, Shaw arrived at the hospital at 9 am and was discharged at 5:30 pm after the infusion and monitoring period... She said the length of the session felt “long but manageable,” and she kept a positive mindset throughout. The actress highlighted that the day’s schedule included pre‑treatment checks, the chemo drip, and a post‑infusion observation period, all of which are standard for HER2‑positive protocols.

Metallic taste and steroid boost: side‑effects explained

Shaw reported that every food tasted “metallic and horrible,” a side‑effect she said is common among chemo patients. She attributed her steady energy to a steroid injection given before the infusion, a practice that helps mitigate nausea and fatigue. The actress emphasized that while the taste distortion is unpleasant, it is temporary and typically resolves after the treatment cycle ends.

Missing medication delivery causes brief delay

In the same video, Shaw clarified that a brief interruption in her treatment was due to a missing medication delivery, not a staffing issue. She thanked the NHS team for handling the delay smoothly and ensuring the correct drug arrived before the infusion resumed . This incident underscores the logistical challenges that can arise even in well‑resourced health systems.

NHS staff praised as ‘angels’ amid public support

Throughout the update, Shaw repeatedly referred to the nurses and doctors as “angels ,” expressing gratitude for their professionalism and compassion. She sent love and courage to other patients undergoing chemotherapy, encouraging a sense of community among those battling cancer. Her public gratitude aligns with a broader wave of celebrity advocacy that raises awareness of cancer treatment experiences.

Will HER2‑targeted therapy follow the chemo?

The report notes that Shaw’s diagnosis is HER2‑positive, which typically involves a combination of chemotherapy and targeted therapies such as trastuzumab. However, she did not specify when the targeted drug will be introduced. Observers are watching to see whether her treatment plan will follow the standard sequence of chemo first, then HER2‑directed agents.

As Shaw continues her treatment, she has already cut her hair in preparation for the expected hair loss and has been open about the mental toll of awaiting each session. Her candid sharing provides a relatable window into the emotional and physical landscape of cancer care.